Novo Holdings A/S as of March 31, 2026
Portfolio Holdings for Novo Holdings A/S
Novo Holdings A/S holds 22 positions in its portfolio as reported in the March 2026 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Edgewise Therapeutics (EWTX) | 13.7 | $169M | 5.4M | 31.50 | |
| Brookfield Corp Cl A Ltd Vt Sh (BN) | 11.5 | $142M | 3.5M | 40.47 | |
| Asml Holding N V N Y Registry Shs (ASML) | 10.2 | $125M | 95k | 1320.83 | |
| Mirum Pharmaceuticals (MIRM) | 9.9 | $122M | 1.3M | 92.38 | |
| Maplight Therapeutics (MPLT) | 6.1 | $75M | 3.7M | 20.33 | |
| salesforce (CRM) | 5.9 | $73M | 393k | 186.67 | |
| Crinetics Pharmaceuticals In (CRNX) | 4.6 | $56M | 1.6M | 36.32 | |
| Enliven Therapeutics (ELVN) | 4.1 | $50M | 1.3M | 39.20 | |
| Vaxcyte (PCVX) | 4.0 | $50M | 860k | 58.11 | |
| Pharvaris N V (PHVS) | 4.0 | $49M | 1.8M | 28.25 | |
| Arrivent Biopharma (AVBP) | 3.6 | $45M | 1.9M | 23.07 | |
| Miragen Therapeutics (VRDN) | 3.2 | $39M | 2.0M | 19.56 | |
| Celldex Therapeutics Com New (CLDX) | 3.1 | $38M | 1.2M | 31.72 | |
| Apogee Therapeutics (APGE) | 3.1 | $38M | 450k | 84.17 | |
| BioMarin Pharmaceutical (BMRN) | 3.0 | $37M | 660k | 56.49 | |
| 4d Molecular Therapeutics In (FDMT) | 2.8 | $34M | 3.7M | 9.31 | |
| Alibaba Group Hldg Sponsored Ads (BABA) | 2.6 | $32M | 257k | 125.46 | |
| Xenon Pharmaceuticals (XENE) | 2.3 | $28M | 485k | 58.15 | |
| Bridgebio Oncology Therapeut Com New (BBOT) | 1.6 | $20M | 2.2M | 8.95 | |
| Valneva Se Sponsored Ads (VALN) | 0.5 | $6.6M | 1.1M | 6.25 | |
| Lanzatech Global Com New (LNZA) | 0.2 | $2.5M | 158k | 16.01 | |
| Marqeta Class A Com (MQ) | 0.1 | $1.8M | 442k | 4.08 |
